Evidence map›Paper›PMID 35978649›Full record

ReviewBioMed research international2022

Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.

Tianyi Liu, Wenhao Zhu, Xiaoyu Zhang, Chuan He, Xiaolong Liu, Qiang Xin, Kexin Chen, Haifeng Wang

RetractedOpen access · hybridAbstract readReviewRetracted Publication
In one paragraph

Review in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tianyi LiuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0002-8560-0819
Wenhao ZhuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0001-6264-8302
Xiaoyu ZhangDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0003-3441-6613
Chuan HeDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0003-0965-7984
Xiaolong LiuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0002-2884-0621
Qiang XinDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0001-7049-8252
Kexin ChenInstitute of Translational Medicine, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0002-1503-6044
Haifeng WangDepartment of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0002-5888-7519
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) is a devastating central nervous system disease caused by accidental events, resulting in loss of sensory and motor function. Considering the multiple effects of primary and secondary injuries after spinal cord injury, including oxidative stress, tissue apoptosis, inflammatory response, and neuronal autophagy, it is crucial to understand the underlying pathophysiological mechanisms, local microenvironment changes, and neural tissue functional recovery for preparing novel treatment strategies. Treatment based on cell transplantation has become the forefront of spinal cord injury therapy. The transplanted cells provide physical and nutritional support for the damaged tissue. At the same time, the implantation of biomaterials with specific biological functions at the site of the SCI has also been proved to improve the local inhibitory microenvironment and promote axonal regeneration, etc. The combined transplantation of cells and functional biomaterials for SCI treatment can result in greater neuroprotective and regenerative effects by regulating cell differentiation, enhancing cell survival, and providing physical and directional support for axon regeneration and neural circuit remodeling. This article reviews the pathophysiology of the spinal cord, changes in the microenvironment after injury, and the mechanisms and strategies for spinal cord regeneration and repair. The article will focus on summarizing and discussing the latest intervention models based on cell and functional biomaterial transplantation and the latest progress in combinational therapies in SCI repair. Finally, we propose the future prospects and challenges of current treatment regimens for SCI repair, to provide references for scientists and clinicians to seek better SCI repair strategies in the future.

Indexed as

Biocompatible MaterialsSpinal Cord InjuriesAxonsHumansNerve RegenerationSpinal CordBiocompatible Materials

Identifiers

PMID35978649
PMCPMC9377911
OpenAlexW4290725612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.